MabThera

Say hello to Roche's worst-case scenario: Teva's Rituxan biosim set to launch in U.S.
Fierce Pharma
Thu, 11/7/19 - 11:05 am
Roche
Teva Pharmaceutical
Celltrion
Rituxan
biosimilars
MabThera
Truxima
Roche clinches EU approval for MabThera in rare autoimmune indication — will it boost dwindling sales amid biosimiar competition?
Endpoints
Fri, 03/15/19 - 09:30 am
Roche
MabThera
Rituxan
Europe
biosimilars
Biosimilars Are Coming After Big Pharma's Bottom Line
Fortune
Tue, 01/12/16 - 02:37 pm
Big Pharma
biosimilars
Roche
AbbVie
MabThera
Herceptin
Avastin
Humira
Janssen
Remicade
Roche nabs European approval for time-saving formulation of Rituxan
Fierce Pharma
Fri, 03/28/14 - 10:56 am
Roche
Europe
Rituxan
MabThera
The 10 best-selling drugs of 2013
Fierce Pharma
Tue, 03/25/14 - 10:07 am
Seretide
Rituxan
Remicade
MabThera
Lantus
Humira
Herceptin
Enbrel
Crestor
Avastin
Advair
Abilify
Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
Yahoo/PR Newswire
Sat, 12/8/12 - 11:23 am
Halozyme
Roche
rituxumab
MabThera
Survey: Many docs will be slow to switch to biosimilar mAbs
Fierce Biotech
Mon, 10/29/12 - 11:42 am
oncologists
mAbs
biosimilars
Roche
MabThera
A.M. Vitals: Roche Gearing Up for Generic Battle
WSJ Online
Mon, 11/1/10 - 08:52 am
Roche
generics
Herceptin
MabThera
Roche seeks to broaden use of cancer drug MabThera
Reuters
Mon, 03/22/10 - 09:57 am
Roche
MabThera
Europe
cancer
non-Hodgkin's lymphoma